The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000152.5(GAA):c.1134C>G (p.Tyr378Ter)

CA401365023

595469 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: e2643a0a-ade5-4d0e-be57-7f62b573760d

HGVS expressions

NM_000152.5:c.1134C>G
NM_000152.5(GAA):c.1134C>G (p.Tyr378Ter)
NC_000017.11:g.80108547C>G
CM000679.2:g.80108547C>G
NC_000017.10:g.78082346C>G
CM000679.1:g.78082346C>G
NC_000017.9:g.75696941C>G
NG_009822.1:g.11992C>G
ENST00000302262.8:c.1134C>G
ENST00000302262.7:c.1134C>G
ENST00000390015.7:c.1134C>G
NM_000152.3:c.1134C>G
NM_001079803.1:c.1134C>G
NM_001079804.1:c.1134C>G
NM_000152.4:c.1134C>G
NM_001079803.2:c.1134C>G
NM_001079804.2:c.1134C>G
NM_001079803.3:c.1134C>G
NM_001079804.3:c.1134C>G

Pathogenic

Met criteria codes 4
PM2_Supporting PVS1 PP4 PM3_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Lysosomal Storage Disorders Variant Curation Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.1134C>G (p.Tyr378Ter) variant in GAA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 7/20, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). Two patients with this variant have been reported with Pompe disease, both treated with enzyme replacement therapy (PMID: 29181627, 31392188) (PP4). One of these individuals is compound heterozygous for the variant and a pathogenic variant in GAA, c.-32-13T>G (PMID: 31392188). The second patient is compound heterozygous for the variant and c.1478C>T (p.Pro493Leu) (PMID: 29181627); the allelic data for this patient will be used in the classification of p.Pro493Leu and was not included here to avoid circular logic (PM3_Supporting). This variant was absent in gnomAD v2.1.1 (PM2_Supporting). There is a ClinVar entry for this variant (Variation ID: 595469). In summary, this variant meets the criteria to be classified as pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases VCEP: PVS1, PP4, PM2_Supporting, PM3_Supporting. (Classification approved by the ClinGen Lysosomal Diseases VCEP, July 3, 2023)
Met criteria codes
PM2_Supporting
This variant is absent in gnomAD v2.1.1.
PVS1
The NM_000152.5:c.1134C>G (p.Tyr378Ter) variant in GAA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 7/20, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PP4
Two patients with this variant have been reported with Pompe disease, both treated with enzyme replacement therapy (PMID: 29181627, 31392188) (PP4).
PM3_Supporting
Two patients with this variant have been reported with Pompe disease. One of these individuals is compound heterozygous for the variant and a pathogenic variant in GAA, c.-32-13T>G, phase unknown (PMID: 31392188) (0.5 points).. The second patient is compound heterozygous for the variant and c.1478C>T (p.Pro493Leu) (PMID: 29181627); the allelic data for this patient will be used in the classification of p.Pro493Leu and was not included here to avoid circular logic. Total points for PM3 = 0.5 (PM3_Supporting).
Approved on: 2023-07-03
Published on: 2023-09-05
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.